FY26 - CAS 1255143-82-8

FY26 is a potent Os (II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer activity, and most remarkably, it improves the selectivity for cancer cells versus normal fibroblasts.

Others

Others

1255053

C23H28F6IN4OsP

822.6

[Os++]123456([#6;v5]-7=[C]1([#6])[#6;v5]2=[#6;v5]3[C]4(=[#6;v5]5-7)[#6](-[#6])-[#6])([#7](=[#7]-[#6]-1=[#7]6-[#6]=[#6]-[#6]=[#6]-1)-c1ccc(cc1)-[#7](-[#6])-[#6])[I-].[P+5]([F-])([F-])([F-])([F-])([F-])[F-] |c:6,17,19,22,24,^1:11,14,28|

-20°C

Ice Packs

Small Compound